Webinar: Standardizing hESC and hiPSC Maintenance and Differentiation

As therapies based on human pluripotent stem cells (hPSCs) move towards the clinic, there is a need to develop standardized protocols free from animal proteins for maintenance and differentiation. This tutorial will describe the development of TeSR™2, animal-protein free medium for the maintenance of hPSCs, the application of AggreWell™ for differentiation to clinically-relevant cell types, and tools for the purification of differentiated cells. Together these reagents provide real solutions to minimize variability and accelerate discovery.

To view the webinar, please complete the form below.

First Name

Last Name

Email Address

Phone Number

Company/Institution

ZIP/Postal Code

Cell Type of Interest

Hold CTRL to select multiple types

State/Province/Region

Country

B cells
CD4 T cells
CD8 T cells
CHO
Dendritic cells
Endothelial and angiogenic cells
Granulocytes and subsets
Hematopoietic cells
Human ESCs and iPSCs
Hybridomas
Lymphoid cells
Mammary epithelial cells
Marrow stromal cells
Mesenchymal stem cells
Monocytes
Mononuclear cell
Mouse ESCs and iPSCs
Muscle cells
Myeloid cells
Neural stem/progenitor cells
Neurons
NK cells
Other T cell subsets
Pancreatic cells
Plasma cells
Prostate epithelial cells
Red blood cells
Regulatory T cells
T cells
Tumor cells